Rifamycin B 产生菌地中海拟无枝酸菌 S699 的全基因组序列。
Whole genome sequence of the rifamycin B-producing strain Amycolatopsis mediterranei S699.
机构信息
Department of Zoology, University of Delhi, Delhi 110 007, India.
出版信息
J Bacteriol. 2011 Oct;193(19):5562-3. doi: 10.1128/JB.05819-11.
Abstract
Amycolatopsis mediterranei S699 is an actinomycete that produces an important antibiotic, rifamycin B. Semisynthetic derivatives of rifamycin B are used for the treatment of tuberculosis, leprosy, and AIDS-related mycobacterial infections. Here, we report the complete genome sequence (10.2 Mb) of A. mediterranei S699, with 9,575 predicted coding sequences.
摘要
地中海拟无枝酸菌 S699 是一种放线菌，能够产生一种重要的抗生素——利福霉素 B。利福霉素 B 的半合成衍生物被用于治疗结核病、麻风病和艾滋病相关分枝杆菌感染。在此，我们报道了地中海拟无枝酸菌 S699 的全基因组序列（10.2 Mb），其中预测有 9575 个编码序列。
相似文献
1
Whole genome sequence of the rifamycin B-producing strain Amycolatopsis mediterranei S699. Rifamycin B 产生菌地中海拟无枝酸菌 S699 的全基因组序列。
J Bacteriol. 2011 Oct;193(19):5562-3. doi: 10.1128/JB.05819-11.
2
Cloning and partial characterization of the putative rifamycin biosynthetic gene cluster from the actinomycete Amycolatopsis mediterranei DSM 46095.来自地中海拟无枝酸菌DSM 46095的假定利福霉素生物合成基因簇的克隆与部分特性分析
Microbiol Res. 2001;156(3):239-46. doi: 10.1078/0944-5013-00108.
3
Complete genome sequence of the rifamycin SV-producing Amycolatopsis mediterranei U32 revealed its genetic characteristics in phylogeny and metabolism. Rifamycin SV 产生菌地中海拟无枝酸菌 U32 的全基因组序列揭示了其在系统发育和代谢中的遗传特征。
Cell Res. 2010 Oct;20(10):1096-108. doi: 10.1038/cr.2010.87. Epub 2010 Jun 22.
4
Thioesterases and the premature termination of polyketide chain elongation in rifamycin B biosynthesis by Amycolatopsis mediterranei S699.硫酯酶与地中海拟无枝酸菌S699在利福霉素B生物合成中聚酮链延伸的提前终止
J Antibiot (Tokyo). 2000 May;53(5):484-95. doi: 10.7164/antibiotics.53.484.
5
A homologue of the Mycobacterium tuberculosis PapA5 protein, rif-orf20, is an acetyltransferase involved in the biosynthesis of antitubercular drug rifamycin B by Amycolatopsis mediterranei S699.结核分枝杆菌PapA5蛋白的同源物rif-orf20是一种乙酰转移酶，参与地中海拟无枝酸菌S699合成抗结核药物利福霉素B的过程。
Chembiochem. 2005 May;6(5):834-7. doi: 10.1002/cbic.200400387.
6
Prediction of Transcription Factors and Their Involvement in Regulating Rifamycin Production in S699.转录因子的预测及其在调控S699中利福霉素生产中的作用
Indian J Microbiol. 2020 Sep;60(3):310-317. doi: 10.1007/s12088-020-00868-5. Epub 2020 Apr 18.
7
Isolation and characterization of 27-O-demethylrifamycin SV methyltransferase provides new insights into the post-PKS modification steps during the biosynthesis of the antitubercular drug rifamycin B by Amycolatopsis mediterranei S699.27-O-去甲基利福霉素SV甲基转移酶的分离与鉴定为地中海拟无枝酸菌S699生物合成抗结核药物利福霉素B过程中聚酮合酶后修饰步骤提供了新见解。
Arch Biochem Biophys. 2003 Mar 15;411(2):277-88. doi: 10.1016/s0003-9861(03)00004-3.
8
Improvement of industry-applied rifamycin B-producing strain, Amycolatopsis mediterranei, by rational screening.通过理性筛选改良工业应用的利福霉素B产生菌地中海拟无枝酸菌。
J Gen Appl Microbiol. 2002 Dec;48(6):329-34. doi: 10.2323/jgam.48.329.
9
8-Deoxy-Rifamycin Derivatives from S699 Strain.S699 菌株来源的 8-脱氧利福霉素衍生物。
Biomolecules. 2020 Sep 2;10(9):1265. doi: 10.3390/biom10091265.
10
Differential mass spectrometry-based proteome analyses unveil major regulatory hubs in rifamycin B production in Amycolatopsis mediterranei.基于差异质谱的蛋白质组学分析揭示了地中海诺卡氏菌 Rifamycin B 生产中的主要调控枢纽。
J Proteomics. 2021 May 15;239:104168. doi: 10.1016/j.jprot.2021.104168. Epub 2021 Mar 2.
引用本文的文献
1
Prospective identification of extracellular triacylglycerol hydrolase with conserved amino acids in 's high G+C genomic dataset.在嗜热栖热放线菌的高G+C基因组数据集中对具有保守氨基酸的细胞外三酰甘油水解酶进行前瞻性鉴定。
Biotechnol Rep (Amst). 2024 Dec 7;45:e00869. doi: 10.1016/j.btre.2024.e00869. eCollection 2025 Mar.
2
Application of Hierarchical Clustering to Analyze Solvent-Accessible Surface Area Patterns in .应用层次聚类分析[具体内容缺失处]的溶剂可及表面积模式
Biology (Basel). 2022 Apr 24;11(5):652. doi: 10.3390/biology11050652.
3
Silver nanoparticles synthesized by the heavy metal resistant strain and its application in controlling red strip disease in sugarcane.由重金属抗性菌株合成的银纳米颗粒及其在控制甘蔗赤条病中的应用。
Heliyon. 2022 May 20;8(5):e09472. doi: 10.1016/j.heliyon.2022.e09472. eCollection 2022 May.
4
Current Molecular Therapeutic Agents and Drug Candidates for .当前用于……的分子治疗剂和候选药物
Front Pharmacol. 2021 Aug 30;12:724725. doi: 10.3389/fphar.2021.724725. eCollection 2021.
5
A Combinatorial Approach of High-Throughput Genomics and Mass Proteomics for Understanding the Regulation and Expression of Secondary Metabolite Production in Actinobacteria.一种用于理解放线菌中次生代谢产物产生的调控与表达的高通量基因组学和大规模蛋白质组学的组合方法。
mSystems. 2021 Aug 31;6(4):e0086221. doi: 10.1128/mSystems.00862-21. Epub 2021 Aug 24.
6
Prediction of Transcription Factors and Their Involvement in Regulating Rifamycin Production in S699.转录因子的预测及其在调控S699中利福霉素生产中的作用
Indian J Microbiol. 2020 Sep;60(3):310-317. doi: 10.1007/s12088-020-00868-5. Epub 2020 Apr 18.
7
In silico prospection of microorganisms to produce polyhydroxyalkanoate from whey: Caulobacter segnis DSM 29236 as a suitable industrial strain.从乳清中生产聚羟基烷酸酯的微生物的计算机探索：鞘氨醇杆菌 DSM 29236 作为一种合适的工业菌株。
Microb Biotechnol. 2019 May;12(3):487-501. doi: 10.1111/1751-7915.13371. Epub 2019 Jan 31.
8
RifZ (AMED_0655) Is a Pathway-Specific Regulator for Rifamycin Biosynthesis in Amycolatopsis mediterranei.RifZ（AMED_0655）是地中海拟无枝酸菌中利福霉素生物合成的特定途径调节因子。
Appl Environ Microbiol. 2017 Mar 31;83(8). doi: 10.1128/AEM.03201-16. Print 2017 Apr 15.
9
Genetics and Genomics of the Genus Amycolatopsis.拟无枝酸菌属的遗传学与基因组学
Indian J Microbiol. 2016 Sep;56(3):233-46. doi: 10.1007/s12088-016-0590-8. Epub 2016 May 2.
10
Genetic manipulation of secondary metabolite biosynthesis for improved production in Streptomyces and other actinomycetes.通过基因操作调控次生代谢物生物合成以提高链霉菌和其他放线菌的产量
J Ind Microbiol Biotechnol. 2016 Mar;43(2-3):343-70. doi: 10.1007/s10295-015-1682-x. Epub 2015 Sep 12.
本文引用的文献
1
Complete genome sequence of the rifamycin SV-producing Amycolatopsis mediterranei U32 revealed its genetic characteristics in phylogeny and metabolism. Rifamycin SV 产生菌地中海拟无枝酸菌 U32 的全基因组序列揭示了其在系统发育和代谢中的遗传特征。
Cell Res. 2010 Oct;20(10):1096-108. doi: 10.1038/cr.2010.87. Epub 2010 Jun 22.
2
Identification of tailoring genes involved in the modification of the polyketide backbone of rifamycin B by Amycolatopsis mediterranei S699.鉴定由地中海拟无枝酸菌S699参与修饰利福霉素B聚酮骨架的定制基因。
Microbiology (Reading). 2005 Aug;151(Pt 8):2515-2528. doi: 10.1099/mic.0.28138-0.
3
BACCardI--a tool for the validation of genomic assemblies, assisting genome finishing and intergenome comparison.BACCardI——一种用于验证基因组组装、辅助基因组完成和基因组间比较的工具。
Bioinformatics. 2005 Apr 1;21(7):853-9. doi: 10.1093/bioinformatics/bti091. Epub 2004 Oct 28.
4
Rifomycin, a new antibiotic; preliminary report.利福霉素，一种新型抗生素；初步报告。
Farmaco Sci. 1959;14(2):146-7.
5
The loading module of rifamycin synthetase is an adenylation-thiolation didomain with substrate tolerance for substituted benzoates.利福霉素合成酶的负载模块是一个对取代苯甲酸具有底物耐受性的腺苷酸化-硫醇化双结构域。
Biochemistry. 2001 May 22;40(20):6116-23. doi: 10.1021/bi010080z.
6
Thioesterases and the premature termination of polyketide chain elongation in rifamycin B biosynthesis by Amycolatopsis mediterranei S699.硫酯酶与地中海拟无枝酸菌S699在利福霉素B生物合成中聚酮链延伸的提前终止
J Antibiot (Tokyo). 2000 May;53(5):484-95. doi: 10.7164/antibiotics.53.484.
7
Regulation and manipulation of the gene clusters encoding type-I PKSs.对编码I型聚酮合酶的基因簇的调控与操纵。
Trends Biotechnol. 2000 Jun;18(6):264-74. doi: 10.1016/s0167-7799(00)01443-8.
8
Characterization of the enzymatic domains in the modular polyketide synthase involved in rifamycin B biosynthesis by Amycolatopsis mediterranei.地中海拟无枝酸菌参与利福霉素B生物合成的模块化聚酮合酶中酶结构域的表征。
Gene. 1998 Aug 31;216(2):255-65. doi: 10.1016/s0378-1119(98)00338-2.
9
Biosynthesis of the ansamycin antibiotic rifamycin: deductions from the molecular analysis of the rif biosynthetic gene cluster of Amycolatopsis mediterranei S699.安莎霉素类抗生素利福霉素的生物合成：来自地中海拟无枝酸菌S699利福生物合成基因簇分子分析的推论
Chem Biol. 1998 Feb;5(2):69-79. doi: 10.1016/s1074-5521(98)90141-7.
10
Cloning and sequence analysis of the putative rifamycin polyketide synthase gene cluster from Amycolatopsis mediterranei.来自地中海拟无枝酸菌的假定利福霉素聚酮合酶基因簇的克隆与序列分析。
FEMS Microbiol Lett. 1998 Feb 15;159(2):201-7. doi: 10.1111/j.1574-6968.1998.tb12861.x.
Zotero 插件